163.50
2.95 (1.84%)
| Previous Close | 160.55 |
| Open | 161.30 |
| Volume | 4 |
| Avg. Volume (3M) | 7,876 |
| Market Cap | 1,927,844,864 |
| Price / Earnings (TTM) | 16.55 |
| 52 Weeks Range | |
| Earnings Date | 12 Aug 2025 |
| TTM Dividend Yield | 1.87% |
| Profit Margin | 7.24% |
| Operating Margin (TTM) | 9.36% |
| Diluted EPS (TTM) | 9.88 |
| Quarterly Revenue Growth (YOY) | -12.30% |
| Quarterly Earnings Growth (YOY) | -42.70% |
| Total Debt/Equity (MRQ) | 22.39% |
| Current Ratio (MRQ) | 1.61 |
| Operating Cash Flow (TTM) | 148.54 M |
| Levered Free Cash Flow (TTM) | 101.22 M |
| Return on Assets (TTM) | 2.08% |
| Return on Equity (TTM) | 4.86% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (GB) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bearish | Bearish | |
| Stock | TECAN GROUP AG TECAN GROUP ORD | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | -0.38 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| TECAN GROUP AG TECAN GROUP ORD | 2 B | 1.87% | 16.55 | - |
| BECTON DICKINSON AND CO BECTON | 47 B | 2.27% | 27.35 | - |
| RESMED INC RESMED ORD SHS | 35 B | 0.80% | 47.35 | - |
| HOLOGIC INC HOLOGIC ORD SHS | 16 B | - | 10.10 | - |
| CONVATEC GROUP PLC ORD 10P | 5 B | 0.02% | 37.49 | 4.38 |
| COOPER COMPANIES INC COOPER ORD | 4 B | - | 4.31 | - |
|
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, and Partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their own names. A majority proportion of Tecan's revenue is generated in the Americas and Europe. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Mid Core |
| % Held by Insiders | 0.26% |
| % Held by Institutions | 62.33% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |